GENETICALLY MODIFIED MICE IN NEUROPHARMACOLOGY
- 30 June 1999
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 39 (6) , 405-419
- https://doi.org/10.1006/phrs.1998.0457
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Of mice and (mad) cows — transgenic mice help to understand prionsTrends in Genetics, 1997
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- Enhanced LTP in Mice Deficient in the AMPA Receptor GluR2Neuron, 1996
- Distinct N-Methyl—aspartate Receptor 2B Subunit Gene Sequences Confer Neural and Developmental Specific ExpressionJournal of Biological Chemistry, 1996
- Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal deathPublished by Elsevier ,1994
- Developmental and regional expression in the rat brain and functional properties of four NMDA receptorsPublished by Elsevier ,1994
- Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout micePublished by Elsevier ,1994
- Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axonsCell, 1992
- The dopamine β-hydroxylase gene promoter directs expression of E. coli lacZ to sympathetic and other neurons in adult transgenic miceNeuron, 1991